Exhibit No. 32.1
Form 10-QSB
SimplaGene USA, Inc.
File No. 333-100110

    Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to
                 Section 906 of the Sarbanes-Oxley Act of 2002.

     In  connection  with the  Quarterly  Report of  SimplaGene  USA,  Inc. (the
"Company") on Form 10-QSB for the period ending  November 30, 2003 as filed with
the Securities  and Exchange  Commission on the date hereof (the  "Report"),  I,
Xinbo Wang,  Chief  Executive  Officer of the  Company,  certify  pursuant to 18
U.S.C.  Section 1350, as adopted  pursuant to Section 906 of the  Sarbanes-Oxley
Act of 2002,  that:  (1) the Report  fully  complies  with the  requirements  of
Section  13(a) or  15(d) of the  Securities  Exchange  Act of 1934;  and (2) the
information  contained in the Report fairly presents,  in all material respects,
the financial condition and results of operations of the Company.



Date: January 8, 2004                           By:   /s/ Xinbo Wang
                                                      Chief Executive Officer

    Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to
                 Section 906 of the Sarbanes-Oxley Act of 2002.

     In  connection  with the  Quarterly  Report of  SimplaGene  USA,  Inc. (the
"Company") on Form 10-QSB for the period ending  November 30, 2003 as filed with
the Securities  and Exchange  Commission on the date hereof (the  "Report"),  I,
Craig S. Laughlin,  Chief Financial Officer of the Company,  certify pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002,  that:  (1) the Report  fully  complies  with the  requirements  of
Section  13(a) or  15(d) of the  Securities  Exchange  Act of 1934;  and (2) the
information  contained in the Report fairly presents,  in all material respects,
the financial condition and results of operations of the Company.



Date: January 8, 2004                           By:   /s/ Craig S. Laughlin
                                                      Chief Financial Officer


A signed  original of this  written  statement  required by Section 906 has been
provided to SimplaGene  USA,  Inc. and will be retained by SimplaGene  USA, Inc.
and  furnished  to the  Securities  and  Exchange  Commission  or its staff upon
request.